HPSI0813i-fpdl_2
WTSIi297-A
General
Cell Line |
|
| hPSCreg name | WTSIi297-A |
| Cite as: | WTSIi297-A (RRID:CVCL_AH04) |
| Alternative name(s) |
HPSI0813i-fpdl_2
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines | |
| Last update | 22nd May 2019 |
| User feedback | |
Provider |
|
| Generator | Wellcome Sanger Institute (WTSI) |
| Distributors | |
External Databases |
|
| HipSci | HPSI0813i-fpdl_2 |
| BioSamples | SAMEA2201450 |
| Cellosaurus | CVCL_AH04 |
| Wikidata | Q54891376 |
General Information |
|
| Publications |
|
| Projects | |
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Donor Information
General Donor Information |
|
| Sex | female |
| Age of donor (at collection) | 45-49 |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA2444543 |
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
| Was the consent voluntarily given? | Yes |
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
| If you do not hold the Donor Consent Form, do you know who does? | No |
| Alternatives to consent | |
| Is there other documentation provided to the donor for consenting purposes? | Yes |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised |
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
| Does consent expressly prevent the derivation of pluripotent stem cells? | No |
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
| How may genetic information associated with the cell line be accessed? | |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
| Name of accrediting authority involved? | East of England- Cambridge Central Research Ethics Committee. |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | No |
hIPSC Derivation
General |
|
| Source cell type |
A leukocyte with a single non-segmented nucleus in the mature form.
Synonyms
|
| Source cell origin |
A fluid that is composed of blood plasma and erythrocytes.
|
| Age of donor (at collection) | 45-49 |
| Collected in | 2013 |
| Source cell line vendor | Cambridge BioResource |
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
| Notes on reprogramming vector detection | CytoTune 1 |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
| Feeder cells |
Mouse embryo fibroblast (MEF) feeder cells |
| Passage method |
Enzymatically
Collagenase and Dispase
|
| CO2 Concentration | 5 % |
| Medium |
Other medium:
Base medium:
Main protein source: Knock-out serum replacement |
Characterisation
Analysis of Undifferentiated Cells
| Pluripotency Score | Novelty Score | |
| 47.975 | 1.444 |
Report
HPSI-fpdl.pluritest.pluripotency_score.20170510.png
pluripotency image
HPSI-fpdl.pluritest.novelty_score.20170510.png
novelty image
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
No
|
Other Genotyping (Cell Line) |
|
| Is there genome-wide genotyping or functional data available? |
Yes
cnv
http://www.hipsci.org/lines/#/lines/HPSI0813i-fpdl_2 Number of regions different from primary tissue: 3; Length of differences from primary tissue: 3
Methylation profiling
https://ega-archive.org/datasets/EGAD00010001139 Text file with probe intensities |
Login to share your feedback, experiences or results with the research community.